Inspire Medical Systems, Inc. (INSP) on Monday reported first-quarter results with revenue rising slightly from last year, though the company swung to a net loss amid higher expenses.
The company posted a net loss of $11.3 million, or $0.39 per share, compared with net income of $3.0 million, or $0.10 per share, in the year-ago period.
Revenue increased to $204.6 million from $201.3 million in the same period last year, reflecting continued demand for its sleep apnea treatment solutions.
For fiscal 2026, Inspire Medical expects revenue in the range of $825 million to $875 million, representing a 4 percent to 10 percent decline compared to 2025. The company also projects an adjusted operating margin of 2 percent to 4 percent and EPS between $0.07 and $0.62, with adjusted EPS expected in the range of $0.75 to $1.25.
INSP is currently trading after hours at $47.08, down $7.76 or 14.15 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.